- 英文名称
- (R)-BoroLeu-(+)-Pinanediol trifluoroacetate
- 分子式
- C17H29BF3NO4
- 分子量
- 379.22
- 中文别名
- (aR,3aS,4S,6S,7aR)-六氢-3a,8,8-三甲基-alpha-(2-甲基丙基)-4,6-甲桥-1,3,2-苯并二氧硼烷-2-甲胺 2,2,2-三氟乙酸盐; (αR)-(1S,2S,3R,5S)-蒎烷二醇-1-氨基-3-甲基丁烷-1-硼酯三氟醋酸盐; (R)-3-甲基-1-((3aS,4S,6S,7aR)-3a,5,5-三甲基六氢-4,6-甲桥苯并[d][1,3,2]二氧戊环-2-基)丁-1-胺 三氟乙酸盐; 硼替佐米中间体1; (1R)-(S)-蒎二醇 1-三氟乙酸铵-3-甲基丁烷-1-硼; (αR,3aS,4S,6S,7aR)-六氢-3a,8,8-三甲基-α-(2-甲基丙基)-4,6-甲撑-1,3,2-苯并二氧杂硼硼烷-2-甲胺 2,2,2-三氟乙酸酯; (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate; (αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate; (R)-BoroLeu-(+)-Pinanediol-CF3COOH; (R)-BoroLeu-(+)-Pinanediol-CF3CO2H; Bortezomib Intermediate 1; (1R)-3-Methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0]dec-4-yl]-1-butanamine trifluoroacetate (1:1); (1R)-3-Methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0]dec-4-yl]butan-1-amine trifluoroacetate (1:1); (1R)-3-methyl-1-[(3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methano-1,3,2-benzodioxaborol-2-yl]butan-1-amine trifluoroacetate (1:1); Acetic acid, 2,2,2-trifluoro-, compd. with (αR,3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-α-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine (1:1)
- 用途
- 化学合成，硼替佐米中间体；用于抗肿瘤药物的合成研究（作为医药中间体）。
